Differentiated Thyroid Cancer with Extrathyroidal Extension: Prognosis and the Role of External Beam Radiotherapy
Open Access
- 1 January 2010
- journal article
- Published by Hindawi Limited in Journal of Thyroid Research
- Vol. 2010, 1-7
- https://doi.org/10.4061/2010/183461
Abstract
A study was performed to identify variables that affected cause-specific survival (CSS) and local relapse-free rate (LRFR) in patients with differentiated thyroid cancer (DTC) and extrathyroid extension (ETE) and to examine the role of external beam radiotherapy (XRT). Prognostic factors were similar to those found in studies of all patients with DTC. In patients with postoperative gross residual disease treated with radiotherapy, 10-year CSS and LRFR were 48% and 90%. For patients with no residual or microscopic disease, 10-year CSS and LRFR were 92% and 93%. In patients older than 60 years with T3 ETE but no gross residual disease postoperatively there was an improved LRFR at 5 years of 96%, compared to 87.5% without XRT (). Patients with gross ETE benefit from XRT and there may be a potential benefit in reducing locoregional failure in patients over 60 years with minimal extrathyroidal extension (T3).
Keywords
This publication has 24 references indexed in Scilit:
- Local and regional control in patients with papillary thyroid carcinoma: specific indications of external radiotherapy and radioactive iodine according to T and N categories in AJCC 6th editionEndocrine-Related Cancer, 2006
- The role of external beam radiotherapy in the treatment of papillary thyroid cancerEndocrine-Related Cancer, 2006
- European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epitheliumActa Endocrinologica, 2006
- Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines TaskforceThyroid®, 2006
- Minimal Extrathyroid Extension Does Not Affect the Relapse-Free Survival of Patients with Papillary Thyroid Carcinoma Measuring 4 cm or Less over the Age of 45 YearsSurgery Today, 2005
- Intensity-modulated radiation therapy for the treatment of nonanaplastic thyroid cancerInternational Journal of Radiation Oncology*Biology*Physics, 2005
- Prognostic factors and the effect of treatment with radioactive iodine and external beam radiation on patients with differentiated thyroid cancer seen at a single institution over 40 yearsClinical Endocrinology, 2005
- What's wrong with Bonferroni adjustmentsBMJ, 1998
- Results of external beam radiotherapy in differentiated thyroid carcinoma: a retrospective study from the Royal Marsden HospitalEuropean Journal of Cancer, 1994
- Prophylactic External Irradiation in Differentiated Thyroid Cancer: A Retrospective Study over a 30-Year Observation PeriodOncology, 1994